9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
Government USA announced that the U.S. Department of Health and Human Services (HHS) will introduce sanctions over 27 medicines which increase from price faster than inflationmeasure that will
Government USA announced that the U.S. Department of Health and Human Services (HHS) will introduce sanctions over 27 medicines which increase from price faster than inflationmeasure that will reduce accounts beneficiaries Medicare.
V Inflation Reduction Actsigned by the President Joe Biden in 2022 included a section that punishes V pharmaceutical to offer medicines at prices that are rising faster than inflation to people with disability or over 65 years old inside health program state Medicare.
“The cost of pay of these drugs for the elderly could drop by $2 to $390 per dose on average on April 1, ”the message says. White House in today’s newsletter.
According to the report HSS Since 2022, “1,200 prescription drugs have increased their prices faster than inflation in 2021,” the year before Biden’s legislation was approved in Congress.
The drugs on the list include one of the best-selling drugs against arthritis, Humira; CAR-T therapy vs. cancer, Yeskarta; and Padcey, another targeted cancer therapy. Complete list of drugs to be return for inflation with their adjustment factors co-insurance following:
Drug manufacturers that raise the price of these drugs higher inflation rate must pay Medicare difference in the form of compensation; if they refuse a refund, they will fined which is equivalent to 125% of that, according to Reuters.
“In addition to making drug companies pay Medicare for price increases faster than inflation, this provision of the Inflation Reduction Act discourages other companies do the same to control excessive magnification drug prices on an annualized basis,” the White House fact sheet said.
The Biden administration said it was the first step towards “reducing the cost of health care for America’s Seniors and Families” as a planned extension negotiations between Medicare and drug companies to cover more drugs.
He also announced that HSS will publish an initial process guide negotiation Price list for drugs covered by Medicare.
Reuters
Source: Aristegui Noticias
As an experienced journalist and author, Mary has been reporting on the latest news and trends for over 5 years. With a passion for uncovering the stories behind the headlines, Mary has earned a reputation as a trusted voice in the world of journalism. Her writing style is insightful, engaging and thought-provoking, as she takes a deep dive into the most pressing issues of our time.
